Evidence map›Paper›PMID 37431183›Full record

ArticleActa biochimica et biophysica Sinica2023

5-HMF attenuates inflammation and demyelination in experimental autoimmune encephalomyelitis mice by inhibiting the MIF-CD74 interaction.

Dongsheng Guan, Yingxia Li, Yinglin Cui, Huanghong Zhao, Ning Dong, Kun Wang, Deqi Ren, Tiantian Song, Xiaojing Wang, Shijie Jin and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Acta biochimica et biophysica Sinica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. MIF Tautomerase Inhibition Protects Neurons From Immune-Mediated Cell Death.Neurology(R) neuroimmunology & neuroinflammation · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. BiogenicFrontiers in medicine · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Dongsheng GuanDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Yingxia LiThe College of Basic Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China.
Yinglin CuiDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Huanghong ZhaoDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Ning DongDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Kun WangDepartment of Pharmacy, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Deqi RenDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Tiantian SongDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Xiaojing WangDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Shijie JinDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Yinghe GaoDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Mengmeng WangDepartment of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou 450002, China.
Henan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neuroprotective role of 5-hydroxymethyl-2-furfural (5-HMF) has been demonstrated in a variety of neurological diseases. The aim of this study is to investigate the effect of 5-HMF on multiple sclerosis (MS). IFN-γ-stimulated murine microglia (BV2 cells) are considered a cell model of MS. With 5-HMF treatment, microglial M1/2 polarization and cytokine levels are detected. The interaction of 5-HMF with migration inhibitory factor (MIF) is predicted using online databases. The experimental autoimmune encephalomyelitis (EAE) mouse model is established, followed by a 5-HMF injection. The results show that 5-HMF facilitates IFN-γ-stimulated microglial M2 polarization and attenuates the inflammatory response. According to the network pharmacology and molecular docking results, 5-HMF has a binding site for MIF. Further results show that blocking MIF activity or silencing

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalMacrophage Migration-Inhibitory FactorsAnimalsFuraldehydeInflammationMiceMice, Inbred C57BLMicrogliaMolecular Docking Simulation5-hydroxymethylfurfuralFuraldehydeMacrophage Migration-Inhibitory Factors5-hydroxymethyl-2-furfuralexperimental autoimmune encephalomyelitisinflammationM2 polarizationmultiple sclerosis

Identifiers

PMID37431183
PMCPMC10448060
OpenAlexW4378804198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.